Analyst Reco. Tarsus Pharmaceuticals, Inc.

Equities

TARS

US87650L1035

Real-time Estimate Cboe BZX Other stock markets 11:47:02 2024-05-21 am EDT			5-day change	1st Jan Change
38.8 ^USD	+0.18%		+2.00%	+91.36%

May. 15	Transcript : Tarsus Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:55 PM
May. 09	Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	May. 09	MT
Goldman Sachs Adjusts Price Target on Tarsus Pharmaceuticals to $30 From $19, Maintains Neutral Rating	Feb. 29	MT
Oppenheimer Raises Tarsus Pharmaceuticals Price Target to $59 From $55, Maintains Outperform Rating	Feb. 28	MT
Goldman Sachs Starts Tarsus Pharmaceuticals With Neutral Rating, $19 Price Target	Nov. 20	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $42, Keeps Buy Rating	Nov. 10	MT
Guggenheim Raises Price Target on Tarsus Pharmaceuticals to $49 From $46, Maintains Buy Rating	23-09-11	MT
HC Wainwright Adjusts Tarsus Pharmaceuticals Price Target to $42 From $50, Maintains Buy Rating	23-08-11	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $50 From $44, Maintains Buy Rating	23-07-26	MT
William Blair Initiates Tarsus Pharmaceuticals at Outperform Rating	23-07-18	MT
HC Wainwright Adjusts Price Target on Tarsus Pharmaceuticals to $44 From $40, Keeps Buy Rating	23-06-26	MT
Guggenheim Raises Price Target on Tarsus Pharmaceuticals to $42 From $40, Maintains Buy Rating	23-06-16	MT
Guggenheim Initiates Coverage on Tarsus Pharmaceuticals With Buy Rating, $40 Price Target	23-05-18	MT
Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $43 From $66, Maintains Outperform Rating	22-11-10	MT
Barclays Starts Tarsus Pharmaceuticals at Overweight With $40 Price Target	22-08-01	MT
Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $66 From $55, Keeps Outperform Rating	22-05-03	MT
HC Wainwright Starts Tarsus Pharmaceuticals at Buy With $40 Price Target	21-12-21	MT
Oppenheimer Initiates Coverage on Tarsus Pharmaceuticals With Outperform Rating, $55 Price Target	21-11-23	MT
TARSUS PHARMACEUTICALS : Raymond James Adjusts Tarsus Pharmaceuticals' Price Target to $65 from $50, Keeps Strong Buy Rating	21-10-08	MT
TARSUS PHARMACEUTICALS : Raymond James Adjusts Tarsus Pharmaceuticals' Price Target to $50 From $39, Maintains Strong Buy Rating	21-06-29	MT
TARSUS PHARMACEUTICALS : Jefferies Adjusts Price Target on Tarsus Pharmaceuticals to $45 From $35, Reiterates Buy Rating	21-06-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Tarsus Pharmaceuticals, Inc.

Equities

TARS

US87650L1035

Analyst Reco.

Filters